AmerisourceBergen Corporation – Consensus Indicates Potential 15.4% Upside
AmerisourceBergen Corporation found using ticker (ABC) have now 11 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 187 and 155 with a mean TP of 171.09. Now with the previous closing price of 148.21 this indicates there is a potential upside of 15.4%. The 50 day MA is 156.3 and the 200 moving average now moves to 135.96. The company has a market capitalisation of $30,797m. Visit the company website at: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,552m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.
AmerisourceBergen Corporation – Consensus Indicates Potential 15.4% Upside
AmerisourceBergen Corporation found using ticker (ABC) have now 11 analysts in total covering the stock. The consensus rating is ''Buy''. The range between the high target price and low target price is between 187 and 155 with a mean TP of 171.09. Now with the previous closing price of 148.21 this indicates there is a potential upside of 15.4%. The 50 day MA is 156.3 and the 200 moving average now moves to 135.96. The company has a market capitalisation of $30,797m. Visit the company website at: https:||www.amerisourcebergen.com [stock_market_widget type="chart" template="basic" color="green" assets="ABC" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $35,552m based on the market concensus. AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers.